• Corporate Programs
  • Gift Cards
  • Advertise
  • People
  • Lists
  • Jobs
  • Classifieds
  • Public Notices
  • Newsletters
  • Podcasts
  • Contact Us
Indianapolis Business Journal
Subscribe Now Log In
Indianapolis Business Journal
  • Newsletters
  • Podcasts
  • Contact Us
  • Advertise
  • People
  • Lists
  • Jobs
  • Classifieds
  • Public Notices
  • News
    • Weekly Paper
      • Digital Edition
      • Purchase Past Issues
    • Diversity
    • Sports Business
    • Small Business
    • Banking & Finance
    • Regional
      • Boone County
      • Hamilton County
      • Hancock County
      • Hendricks County
      • Johnson County
      • Madison County
      • Morgan County
      • Shelby County
      • Other Counties
    • More Industries
      • Communications
      • Education & Workforce Development
      • Energy & Environment
      • Government & Economic Development
      • Law
      • Manufacturing
      • Philanthropy
      • Transportation, Distribution & Logistics
      • Workplace Issues
    • Company News
      • Eli Lilly and Co.
      • Simon Property Group
      • Elevance
      • More Public Companies
      • More Private Companies
    • Corrections
    • Multimedia
      • Photo Galleries
      • Videos
      • IBJ mobile apps
      • RSS Feeds
  • Real Estate
    • Retail
    • Restaurants
    • Commercial
    • Residential
  • Politics
  • North of 96th
  • Health Care
  • Tech
  • Opinion
    • Forefront
    • Viewpoint
    • Editorials
    • Letters to the Editor
  • Events
    • 20 in Their Twenties
      • 2025 Honorees
      • 2025 Event Video
      • 2025 Event Photos
      • Past Recipients
      • Nominate
      • Register for event
    • Bourbon & Brokers
    • CEO of the Year & C-Suite Awards
    • Commercial Real Estate & Construction Power Breakfast
    • Economic Forecast
    • Education Power Breakfast
    • Excellence in Health Care
      • 2026 Event Photos
      • 2026 Honorees
      • 2026 Event Video
      • Past Recipients
      • Nominate
      • Register for Event
    • Fast 25
      • 2026 Honorees
      • 2026 Event Video
      • 2025 Event Photos
      • Past Recipients
      • Nominate
      • Register for Event
    • Forty Under 40
      • 2026 Honorees
      • 2026 Event Video
      • 2026 Event Photos
      • Past Recipients
      • Nominate
      • Register for Event
    • Gleaners – Hunger & Health
    • Health Care & Benefits Power Breakfast
    • Indiana 250
      • 2025 Photo Gallery
      • Indiana 250 Website
    • Innovate Indiana Series
      • Innovate Northeast Indiana – Fort Wayne
      • Innovate Southwest Indiana – Evansville
      • Innovate Northwest Indiana – Valparaiso
      • Innovate West Central Indiana – Terre Haute
      • Innovate Southern Indiana – Jeffersonville – Clarksville
      • Innovate East Central Indiana – Muncie
      • Innovate North Central – South Bend – Elkhart
      • Innovate South Central Indiana – Bloomington
      • Innovate Central Indiana – Indianapolis
    • Leadership in Law
    • Life Sciences Power Breakfast
    • Nonprofit Excellence Awards
      • 2025 Honorees
    • Technology Power Breakfast
    • Women of Influence
      • 2025 Honorees
      • 2025 Event Video
      • 2025 Event Photos
      • Past Recipients
      • Nominate
      • Register for event
  • Awards
    • Submit Award Nominations
    • Award Recipients
      • 20 in their Twenties
      • CEO of the Year and C-Suite Awards
        • Past Recipients
        • 2025 Honorees
      • Fast25
      • Excellence in Health Care
        • Past Recipients
        • 2026 Honorees
        • Nominations
      • HR Impact Awards
      • Michael A. Carroll Award
      • Nonprofit Excellence Awards
      • Women of Influence
        • 2025 Honorees
        • Past Recipients
      • Forty Under 40
        • Class of 2026
        • Past Recipients
      • Tech Exec of the Year
        • 2024 Honorees
        • Past Recipients
  • Content Studio
    • Thought Leadership
      • Student success comes first
      • How IU is leading in incorporating AI into education
      • Listening to build culture, celebrate teams
      • In commercial real estate, trust turns relationships into long-term successes.
      • After 30 years, Women’s Fund of Central Indiana goes statewide, now Women’s Foundation of Indiana
      • Why Quality Facilities are a Mission-Critical Investment for Nonprofits
      • How nonprofits can adapt to a shifting financial landscape
      • Planning considerations for business succession
      • How Organizations Can Spend Less Time on Investments and More Time on Impact
      • Bringing a personal touch to financial planning
      • A prescription for better health
      • Small and mid-sized firms shouldn’t take cybersecurity risks lightly
      • It’s time to take a scalpel to the business school
      • Advancing access, affordability, and workforce readiness
      • Addressing Indiana’s workforce transformation needs
      • Rethinking Risk: How Climate Change is Reshaping Insurance
      • Pacers Foundation, Gleaners team up to feed hungry Hoosiers
    • Thought Leadership Topics
    • Sponsored Content
      • A Flexible, Affordable Way to Get Your Degree
      • Good Intentions Are Not Enough: What Many Legacy Plans Miss
      • Harrell-Fish (HFI): Building for the Future While Staying Rooted in Purpose
      • What We Owe New Nurses, And Why It Matters Now
      • New Construction AI Platform Enters Indiana, Giving General Contractors ‘God Mode’ for Early-Stage Projects
      • Reauthorize The FirstNet Authority
      • Building wealth matters. Building a legacy matters more.
      • The essential role of a health plan in Indiana
      • New Initiative Protects Indiana Employers and Working Families from Increased Healthcare Costs
      • Addressing Indiana’s Healthcare Affordability Crisis
      • FirstNet: A Public-Private Partnership That Keeps America Safe
    • Sponsored Content Samples
      • Sponsored Content – Emails
      • Sponsored Content – Print
      • Custom Videos
    • Business Cares Sites
      • Business Cares: Corporate Social Responsibility
      • Business Cares Breast Cancer Awareness
      • Business Cares Diversity, Equity & Inclusion
      • Business Cares Heart Health Awareness
    • Career Ready Indiana
      • 2025-26 – Earn & Learn
      • 2024-25 – Build Your Talent Pipeline
      • 2024-25 – Build Your Job Skills
      • 2023-24 – Need Talent? Grow Your Own
      • 2022-23 – Looking for Talent? Employers, We’ve Got You Covered!
      • 2021-22 – Hoosiers Talk About Why Indiana is a Great Place for Your Career
      • 2020-21 – Today’s College Students Older, Wiser
      • 2019-20 – Former Indy 500 Driver Crosses College Finish Line
    • IEDC Regional Reports
    • Contact Us
Subscribe Now Log In
  • The Tip-Off
  • Weekly Paper
  • Latest IBJ Forefront
  • Excellence in Health Care 2026
  • Forty Under 40 2026
  • Corporate 100 2026
  • Corrections
Home » Search

Search Results

4,410 results for '\"eli lilly\"'

  • Sort By
    • Relevance
    • Oldest
    • Newest
  • Date
    • Any Time
    • Past Day
    • Past Week
    • Past Month
    • Past Year
    • Custom Date Range
  • Content Type
    • {{post_type.label}}
  • Topics
  • Authors
  • Reset

Articles

Ex-Lilly executives open ‘trials’ clinic: Centurion expects high demand from drug firms

October 20, 2008

A new clinic that is on the cusp of conducting human trials in Indianapolis could distinguish itself as a key player in drug development, not only within the state, but nationally as well. Centurion Clinical Research LLC serves pharmaceutical companies and medical-device makers that need to test their products before they can be approved for widespread use. That first phase, in which healthy people are paid to participate in the overnight studies, is critical in determining the safety and success…

BEHIND THE NEWS: Lechleiter went toe to toe with Icahn to cut megadeal

October 20, 2008

Eli Lilly and Co. had been salivating over ImClone Systems Inc. for more than two years when, on July 25 of this year, its senior executives received a formal staff recommendation to contact the company and make an overture. So it must have come as quite a jolt to Lilly brass when, just six days later, Bristol-Myers Squibb announced that it was offering to buy the 83 percent of ImClone it didn’t already own for $60 a share, or $4.5…

Report: Lilly drug decision unlikely before March

October 17, 2008

A pharmaceutical industry publication says the U.S. Food and Drug Administration is convening a February meeting to discuss prasugrel, a blood-thinner Eli Lilly and Co. hopes will be its next blockbuster. The move likely would delay a decision on the new drug until March, according to The Pink Sheet, a weekly publication that covers regulatory […]

Lilly commences ImClone tender offer

October 14, 2008

Eli Lilly and Co. has commenced its tender offer for New York-based ImClone Systems Inc., the Indianapolis-based drugmaker announced today. Lilly agreed on Oct. 6 to pay $70 a share in cash to acquire ImClone, for a total purchase price of $6.5 billion. Two of ImClone’s largest shareholders-ImClone Chairman Carl Icahn and New York-based Bristol-Myers […]

Lilly buys ImClone as part of strategy to capitalize on cancer-drug market

October 13, 2008

Eli Lilly and Co. has written a $6.5 billion IOU to acquire the cancer drugs of ImClone Systems Inc. Cancer drugs are now
the best-selling class of drugs in the world and one of the fastest growing.

EDITORIAL: Lilly looks forward with ImClone deal: CEO Lechleiter taking bold steps

October 13, 2008

Lilly looks forward with ImClone deal CEO Lechleiter taking bold steps It’s premature to pass judgment on Eli Lilly and Co.’s $6.5 billion plan to acquire biotech firm ImClone Systems Inc., but the giant deal is one more sign that relatively new CEO John Lechleiter isn’t afraid to make bold moves on Lilly’s behalf. The local drugmaker agreed Oct. 6 to pay $70 a share for New York-based ImClone, maker of blockbuster cancer drug Erbitux, outbidding an earlier offer of…

Endowment giving $2.8M to BioCrossroads

October 8, 2008

Lilly Endowment will donate $2.8 million in its latest gift to BioCrossroads Inc., the development group that promotes life sciences business in central Indiana. The money will fund BioCrossroads’ educational and scientific initiatives through 2010. To date, the endowment has given $16 million to fund such BioCrossroads projects as the Indiana Health Information Exchange, the […]

Lilly settles Zyprexa claims for $62M

October 7, 2008

Eli Lilly and Co. promised to dole out $62 million to 32 states to settle claims that the Indianapolis drugmaker improperly marketed its bestselling drug, the antipsychotic Zyprexa. Indiana will get $1.6 million of the total, according to Attorney General Steve Carter. Attorneys general from the 32 states had claimed that Lilly illegally promoted Zyprexa […]

UPDATE: Investors skeptical of $6.5B Lilly buy

October 6, 2008

Wall Street didn’t embrace Eli Lilly and Co. CEO John Lechleiter’s plan to acquire biotech firm ImClone Systems Inc., a maker of cancer drugs, for $6.5 billion. Lilly shares tumbled 5 percent today to less than $40 a share-a new 52-week low. One analyst called Lilly’s deal “an act of desperation” as the company struggles […]

UPDATE: Lilly CEO calls deal an ‘important step’

October 6, 2008

Eli Lilly and Co.’s planned acquisition of ImClone Systems Inc. is its boldest move yet to replace revenue it will lose once patent coverage for its bestseller Zyprexa expires in three years. The Indianapolis-based drugmaker announced this morning it would pay $6.5 billion in cash to acquire New York-based ImClone, a biotech firm that develops […]

Analysts fault FDA for market delay of Lilly’s prasugrel:

October 6, 2008

Eli Lilly and Co.’s frustrating attempt to get a ruling from federal regulators on its experimental blood thinner prasugrel may be a test case of life under a more cautious-and understaffed-U.S. Food and Drug Administration. That’s the opinion taken by many pharmaceutical analysts after the FDA missed its self-imposed Sept. 26 deadline to make a ruling on prasugrel. The FDA already had delayed its decision by three months after it agreed to give prasugrel a “priority” review lasting six months….

Pathway Productions gets new owner, new CEO

October 6, 2008

Pathway Productions, one of the city’s highest-profile video production firms, has a new owner, a new CEO and a new plan to blaze a trail to prosperity. Michael Husain, who founded the company from his basement in 1996, earlier this year quietly sold a majority stake to Mays Chemical Co. President William Mays, who in turn named Jerald Harkness the new CEO.

Super Bowl group hires Sports Corp. official as CEO

October 6, 2008

The woman chosen as president and CEO of the city’s Super Bowl host committee isn’t exactly a household name, but those who hired her think she’ll make Indianapolis the best host city ever. Allison Melangton, 46, is the first paid member of the 2012 Indianapolis Super Bowl Host Committee, and is expected to throw planning and organization into overdrive over the next 30 days.

EDITORIAL: Signs of hope as many retreat: Some shrug off economic fears

October 6, 2008

Signs of hope as many retreat Some shrug off economic fears The front page of this week’s IBJ tells of companies that are in dire straits-or out of business-after banks, jittery about a financial collapse, called their loans or canceled their credit line. Stories like these put a local face on the economic crisis that has gripped the American psyche in the last two weeks unlike anything since the terrorist attacks of 9/11. Anyone who didn’t realize credit’s vital role…

IU makes plans to hatch more businesses: Incubator in Bloomington hopes to duplicate success of local Emerging Technologies Center

October 6, 2008

Ground should be broken late this month or in early November, with completion expected by summer. Cost of the 40,000-square-foot facility-4,000 square feet smaller than the one here-is estimated in the $8 million to $10 million range. While it may be a bit smaller in size, the scope is broader. The new incubator will promote both life sciences companies and information technology firms. That goal differs from the mission of the existing IU Emerging Technologies Center on 10th Street, which…

Pangea Lingua suddenly says adieu: Translation firm had served Indiana’s largest companies

October 6, 2008

Not long ago, translation firm Pangea Lingua was one of Indianapolis’ womenowned-business success stories. Its founder, Tamra Lewis, was named to IBJ’s “40 Under 40” list in 1999. Over the next few years, lengthy profiles followed in the pages of The Indianapolis Star and on the cover of Indianapolis Woman magazine. Yet suddenly, the company is out of business-apparently in part because other firms were undercutting it on price. Lewis, who’s in her early 40s, did not return calls left…

Lilly cancer drug deal worth up to $520M

October 3, 2008

Indianapolis-based Eli Lilly and Co. will pay privately held Deciphera Pharmaceuticals LLC of Lawrence, Kan., as much as $520 million to develop and win regulatory approval for four types of cancer drugs, Bloomberg News reported.The companies will collaborate to develop cancer drugs using a Deciphera discovery that seeks to inhibit an enzyme linked to cancer […]

Lilly, ImClone shares steady amid merger talk

October 2, 2008

Stock in Indianapolis-based Eli Lilly and Co. and ImClone Systems Inc. fell slightly today – a day after reports surfaced that Lilly has made a $6.1 billion offer for the New York-based cancer drug developer. Lilly shares fell 40 cents to $43.30, and ImClone stock slipped 11 cents to $65.24. The declines came on a […]

ImClone: Suitor due diligence finished

October 2, 2008

ImClone Systems Inc., the New York cancer drug developer said to be in talks to be acquired by Indianapolis-based Eli Lilly and Co., disclosed late yesterday that the suitor had “completed due diligence and made a proposal not subject to financing or further due diligence.” ImClone didn’t identify the suitor, but said it is a […]

Report: Lilly offers $6.1B for ImClone

October 1, 2008

Eli Lilly and Co. is in late talks to acquire ImClone Systems Inc. for $6.1 billion, according to a report on The Wall Street Journal’s Web site. The New York biotech firm develops various medicines for cancer treatments. Lilly would pay $70 per share for ImClone, the Journal said. The deal would be one of […]

« Previous 1 … 194 195 196 197 198 … 221 Next »
Back To Top
  • Subscriptions
    • Online & Print Subscriptions
    • FREE eNews
  • Submit to Edit
    • Submit People
    • Submit Records
    • IBJ Awards
  • IBJ.com Account
    • My Account
    • Register
  • Events
    • Upcoming IBJ Events
    • Award Nominations
    • Event Sponsorship Opportunities
  • Support & Information
    • Customer Service
    • Contact Us
    • Career Opportunities
    • Reprints
  • Advertising
    • IBJ Advertising
    • Contacts
    • Classifieds
    • Legal Notices
    • Submit Advertising
  • Multimedia
    • Photo Galleries
    • Videos
    • IBJ Mobile App
  • IBJ.com
    • Book of Lists
    • Editorial Calendar
    • IBJ Digital Newspaper
    • Past Print Issues
    • Magazines/Supplements
    • IBJ Store
  • Online Products
    • Purchase Past Issues
    • Bookstore
  • IBJ Media
  • Inside INdiana Business
  • The Indiana Lawyer
  • Indiana 250
  • AdEndeavor
Copyright © 2026 All Rights Reserved Privacy Policy | Terms of Service